FDA Import Refusal 799-2680545-9/11/4 — Teva Canada Limited
The FDA refused shipment 799-2680545-9/11/4 from Teva Canada Limited (Canada) on August 23, 2024. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 23, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75